Compounds > methanol

methanol and indole-3-carbinol

methanol has been researched along with indole-3-carbinol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breeze, RG; Carlson, JR; Potchoiba, MJ1
Chen, CS; Chiu, CF; Kulp, SK; Lin, CH; Ma, Y; Sargeant, A; Tsai, CH; Tsai, MH; Wang, D; Weng, JR; Yang, HC1
Chen, CS; Kulp, SK; Omar, HA; Patel, T; Sargeant, AM; Wang, D; Weng, JR1
Alalaiwe, A; Fang, JY; Huang, TH; Lin, ZC; Weng, JR1

Other Studies

4 other study(ies) available for methanol and indole-3-carbinol

ArticleYear
Metabolism and pneumotoxicity of 3-methyloxindole, indole-3-carbinol, and 3-methylindole in goats.
    American journal of veterinary research, 1982, Volume: 43, Issue:8

    Topics: Acute Disease; Animals; Female; Goats; Indoles; Male; Methanol; Oxindoles; Pulmonary Edema; Pulmonary Emphysema; Skatole

1982
A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells.
    Cancer research, 2007, Aug-15, Volume: 67, Issue:16

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Dimerization; Drug Stability; Humans; Indoles; Male; Methanol; Mice; Mice, Nude; Models, Molecular; Prostatic Neoplasms; Signal Transduction; Xenograft Model Antitumor Assays

2007
Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma.
    Molecular pharmacology, 2009, Volume: 76, Issue:5

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Female; Humans; Indoles; Liver Neoplasms, Experimental; Methanol; Mice; Mice, Nude; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction; Xenograft Model Antitumor Assays

2009
Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 119

    Topics: Administration, Cutaneous; Animals; Cell Line; Drug Delivery Systems; Humans; Imiquimod; Indoles; Male; Methanol; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; NF-kappa B; Nitrobenzenes; Phosphorylation; Psoriasis; Transcription Factor AP-1; Tumor Necrosis Factor-alpha

2019